Journals / Annals of Medical Research / 2022 / Cilt: 29 - Sayı: 6

Relationship of zonulin levels with thyroid function and metabolic parameters in Hashimoto’s Thyroiditis

Pages
530–533
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

More studies are needed to prove that impaired intestinal permeability is among the causes of decreased thyroid function.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Intestinal permeability is one of the factors responsible for the pathogenesis of many immune-related diseases, one of which is Hashimoto’s-thyroid (HT).
📊
Key Findings & Data:Materials and Methods: The study was conducted with 43 women newly diagnosed with HT and a control group of 30 matched with them.
💡
Conclusion & Impact:More studies are needed to prove that impaired intestinal permeability is among the causes of decreased thyroid function.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Intestinal permeability is one of the factors responsible for the pathogenesis of many immune-related diseases, one of which is Hashimoto’s-thyroid (HT). We used zonulin as a biomarker of intestinal permeability in this cross-sectional study. We aimed to determine serum zonulin levels in individuals diagnosed with HT and to investigate the relationship between zonulin and autoimmunity biomarkers, thyroid function and metabolic parameters. Materials and Methods: The study was conducted with 43 women newly diagnosed with HT and a control group of 30 matched with them. The evaluated parameters were thyroperoxidase-antibody (TPO-AB), thyroglobulin-antibody (Tg-AB), thyroid hormone profile, metabolic parameters and zonulin levels. Results: Higher levels of TSH, TPO-AB, Tg-AB, TG and TC were measured in the HT group compared to controls (P < 0.005). The means of zonulin in HT.patients were significantly higher than in the control group (P < 0.005). Conclusion: The correlations between zonulin levels and TSH and TPO-AB among all subjects in this study support the idea that intestinal permeability is a distinguishing feature in the conditions causing the formation of immunological hypersensitivity in HT. More studies are needed to prove that impaired intestinal permeability is among the causes of decreased thyroid function.

🔖

Cite This Article

DENİZ, Ç. D., GÖNÜLALAN, G., SAYIN, K., KOZANHAN, B. (2022). Relationship of zonulin levels with thyroid function and metabolic parameters in Hashimoto’s Thyroiditis. Annals of Medical Research, Cilt: 29 - Sayı: 6, 530–533. https://ajindex.com/articles/445655

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Burek CL, Rose NR. Autoimmune thyroiditis and ROS. Autoimmun Rev. 2008;7(7): 530–7
  2. Orgiazzi J. Thyroid autoimmunity. Presse Med. 2012;41:611–25
  3. Fountoulakis S, Tsatsoulis A. On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clin Endocrinol. 2004;60(4):397–409
  4. Catureglia P, DeRemigisa A, Rosea NR. Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun Rev. 2014; 13: 391– 7
  5. Fasano A. Leaky Gut and Autoimmune Diseases. Clinic Rev Allerg Immunol. 2012; 42:71 6. Abreu MT. Toll-like receptor signaling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol. 2010; 10:131–44
  6. Fasano A. Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol. 2008; 173:1243–52
  7. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009; 124:3–20 9. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011; 91:151–75
  8. Mäkelä M, Vaarala O, Hermann R et al. Enteral virus infections in early childhood and an enhanced type 1 diabetesassociated antibody response to dietary insulin. J Autoimmun. 2006; 27:54– 61 11. Mojibian M, Chakir H, Lefebvre DE, Crookshank JA, Sonier B, Keely E, Scott FW. Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes. 2009; 58:1789–96
  9. Westall FC. Abnormal hormonal control of gut hydrolytic enzymes causes autoimmune attack on the CNS by production of immune-mimic and adjuvant molecules: a comprehensive explanation for the induction of multiple sclerosis. Med Hypotheses. 2007; 68:364–9
  10. Yokote H, Miyake S, Croxford JL, Oki S, Mizusawa H, Yamamura T. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol. 2008; 173:1714–23
  11. Edwards CJ. Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis. J Rheumatol. 2008; 35:1477–97 15. Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci USA. 2009;106:16799–804
  12. Sapone A, de Magistris L, Pietzak M, Clemente MG, Tr